Toronto - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ('Leveljump' or the 'Company'), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has closed its acquisition of 23.8% of the issued and outstanding shares of each of Shaw Vision Inc. ('Shaw Vision') and Shaw Lens Inc. ('Shaw Lens') from a minority shareholder (the 'Shaw Acquisition'), as originally announced on August 31, 2021.

The Shaw Acquisition has been approved by the boards of Shaw Vision and Shaw Lens. Closing of the Shaw Acquisition and has received final consent of the TSX Venture Exchange. All securities issued will be subject to a hold period of four months and one day pursuant to applicable securities laws. Both Shaw Vision Inc. and Shaw Lens Inc. are Toronto-based privately owned federal corporations.

About Shaw Lens and Shaw Vision

Shaw Lens holds a U.S. patent protected lens technology that can solve a condition for people who wear glasses, known as aniseikonia. It is a condition that causes each eye to perceive the size of objects differently. Issues related can include headaches, double vision, disorientation or dizziness, tearing, eye pain or fatigue, sensitivity to light, visual acuity issues and trouble reading, as well as nausea...according to the Columbia University Department of Ophthalmology... '20- 30% of the general spectacle wearing population may have a measurable amount of aniseikonia.' The potential market size for corrective lenses for aniseikonia is over 800 million people that may be currently living with some degree of aniseikonia and its relative effects.

Contact:

Mitchell Geisler

Chief Executive Officer

E: info@leveljumphealthcare.com

T: (833) 840-2020

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains 'forward-looking information' within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

(C) 2021 Electronic News Publishing, source ENP Newswire